Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Renal Corpuscle

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...

Nephrons

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...

Transcytosis of IgG

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Proactive Engagement of Patients With Advanced Chronic Kidney Disease to Reduce Clinical Complications: The Kaiser Permanente Northern California Experience.

The Permanente journal·2026

Same author

Proteinuria Screening in the Primary Care Office: A Review and a Quality Improvement Project.

The Permanente journal·2025

Same author

Comparison of Apixaban With Warfarin in Patients on Dialysis Within an Integrated Health Care System.

The Permanente journal·2025

Same author

Nurse-Assisted Peritoneal Dialysis: A Pilot Feasibility Program.

Clinical journal of the American Society of Nephrology : CJASN·2025

Same author

Plasmapheresis in ANCA-Associated Vasculitis with Active Kidney Involvement in the United States (2016-2020): A Cross-Sectional Study.

Kidney360·2024

Search research articles

Related Experiment Video

Updated: Jun 8, 2025

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

Immunoglobulin A Nephropathy: A Review.

Sulaiman Aseem¹, Sijie Zheng^2,3,4

¹Miramonte High School , Orinda, CA, USA.

The Permanente Journal

|November 5, 2024

Summary

Immunoglobulin A nephropathy (IgAN) is a common kidney disease, particularly in the Pacific and Europe. Recent advances offer new hope for diagnosis and treatment of this glomerulopathy.

Keywords:

IgAN clinical renal

More Related Videos

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

Related Experiment Videos

Last Updated: Jun 8, 2025

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

Area of Science:

Nephrology
Immunology
Genetics

Background:

Immunoglobulin A nephropathy (IgAN) is a primary glomerulopathy with significant regional prevalence variations.
Genetic and environmental factors, alongside practice patterns, influence IgAN distribution.
IgAN is most prevalent in the Pacific region and Europe, and rare in Africa.

Purpose of the Study:

To provide a comprehensive review of Immunoglobulin A nephropathy.
To summarize the history, pathogenesis, and diagnostic approaches for IgAN.
To highlight recent advancements in IgAN management, including clinical trials and therapies.

Main Methods:

Literature review of IgAN history, pathogenesis, and diagnosis.
Analysis of epidemiological data on IgAN prevalence.
Synthesis of information on current and emerging IgAN treatments.

Main Results:

IgAN exhibits distinct geographical prevalence patterns.
Understanding of IgAN pathogenesis has advanced significantly.
Management strategies for IgAN have evolved with new therapeutic options.

Conclusions:

IgAN remains a significant global health challenge with complex etiology.
Ongoing research and clinical trials are crucial for improving IgAN patient outcomes.
Further investigation into unanswered questions is needed to refine IgAN care.